Abstract
Background and Objectives: Universal depression screening is recommended in U.S. primary care to identify and connect adolescents to treatment. However, the longitudinal impact of screening on diagnosis and subsequent mental health care access remains under-explored. This study aimed to determine if screening leads to higher rates of diagnosis and treatment.
Methods: This longitudinal cohort study utilized insurance claims data from 57,732 adolescents (ages 12–18) who had routine well-visits between 2014 and 2017. Using propensity score matching (PSM), the researchers compared adolescents who were screened for depression to a matched cohort of unscreened peers. Outcomes included depression and mood-related diagnoses, antidepressant prescriptions, and psychotherapy over a 6-month follow-up period.
Results: Screened adolescents were 30% more likely to receive a depression diagnosis (RR=1.30, 95% CI=1.11-1.52) and 17% more likely to receive a mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27). However, screening did not significantly increase the likelihood of receiving antidepressant prescriptions (RR=1.11) or psychotherapy (RR=1.13). Associations were generally stronger among female participants.
Conclusions: While screening successfully identifies youth with depression, it does not necessarily lead to increased treatment uptake. Future efforts must focus on bridging the gap between identification and care.
Introduction
Depression is a leading cause of disability among adolescents, with U.S. prevalence rates rising steadily over the last decade. In response, the U.S. Preventive Services Task Force (USPSTF) recommends universal screening for youth aged 12–18 in primary care settings. Despite these recommendations, a critical question remains: Does the act of screening actually improve clinical outcomes by connecting youth to necessary care?
Because universal screening is a standard clinical recommendation, conducting randomized controlled trials (RCTs) is ethically complex. This study addresses this evidence gap by using observational insurance data and advanced statistical matching to simulate the rigor of a controlled trial.
Methods
Study Design and Data Source
The researchers conducted a longitudinal cohort study using healthcare and pharmacy claims data from Highmark Health, a large non-profit insurer in the Eastern United States (Pennsylvania, West Virginia, and Delaware). The study period spanned from 2014 to 2017.
Participant Selection
The sample included 57,732 adolescents who met the following criteria:
- Aged 12–18 at the time of a routine well-visit.
- No history of depression or mental health treatment in the six months prior to the visit.
Statistical Analysis
To account for selection bias—the tendency for doctors to screen patients they already suspect are depressed—the team used Propensity Score Matching (PSM). Screened adolescents (n=14,433) were matched with unscreened peers (n=43,299) based on age, sex, race, rurality, prior healthcare usage, and provider specialty. Risk Ratios (RRs) were then calculated using log-binomial regression to compare outcomes over a six-month follow-up.
Key Results
The Identification Success
Screening proved to be an effective tool for clinical identification. Compared to the matched unscreened group, screened adolescents were:
- 30% more likely to be diagnosed with depression (RR=1.30, 95% CI=1.11-1.52).
- 17% more likely to receive a broader mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27).
The Treatment Gap
Despite the increase in diagnoses, there was no statistically significant increase in treatment initiation for the overall cohort:
- Antidepressant prescriptions: RR=1.11 (95% CI=0.82-1.51).
- Psychotherapy: RR=1.13 (95% CI=0.98-1.31).
Gender Differences
When the data was stratified by sex, a notable difference emerged. Screened females were significantly more likely to receive psychotherapy (RR=1.22) following a screen, an effect not observed in males. This suggests that screening may be more effective at capturing internalizing symptoms common in females or that females face fewer stigmas when seeking follow-up care.
Discussion
The "Implementation Gap"
The findings highlight a "leaky pipeline" in adolescent mental health. While primary care providers are increasingly adopting screening guidelines—with rates in this study rising from 2% in 2014 to 13.6% in 2017—the transition from diagnosis to intervention remains a major hurdle. Identifying a teen in need is only the first step; structural barriers, provider shortages, and patient-level factors continue to impede access to care.
Limitations
As with all claims-based research, this study has limitations. Claims data indicates that a screen occurred but does not provide the result of that screen. Additionally, the data may not capture care provided outside of the insurance network, such as school-based counseling or services paid for out-of-pocket.
Conclusion and Future Directions
Universal depression screening is a vital diagnostic tool, but it is not a panacea. To improve adolescent outcomes, the focus must shift toward integrated care models. Strategies such as "warm hand-offs"—where a primary care doctor introduces the patient to a behavioral health specialist during the same visit—and collaborative care frameworks are essential to ensure that a positive screen leads to meaningful treatment.
Summary updated